Sign in
4

Changes in Ownership

PULSE BIOSCIENCES, INC. Filed Acc 0001437749-25-030665

Chief Commercial Officer sold 4,600 shares at $18.53 ($85,238)

  • Chief Commercial Officer acquired 4,600 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Danahy Kevin Patrick Chief Commercial Officer 2025-10-02 Option exercise 10b5-1 +4,600 $1.53 $7,038 47,898 D
Danahy Kevin Patrick Chief Commercial Officer 2025-10-02 Sale 10b5-1 −4,600 $18.53 $85,238 43,298 D
Derivatives
Danahy Kevin Patrick Chief Commercial Officer 2025-10-02 Option exercise · Stock Option (right to buy) 10b5-1 −4,600 425,000 D
Open-market sales · 4,600 sh · avg $18.53 · $85,238
Loading xslF345X05/rdgdoc.xml…